Olema Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Olema Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Olema Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.57M, a 38.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.57M -$991K -38.7% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.81M -$124K -6.4% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.06M -$165K -7.43% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.29M -$204K -8.18% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.56M -$206K -7.45% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.94M -$1.09M -36% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.22M -$770K -25.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $2.5M -$751K -23.1% Dec 31, 2022 10-K 2024-03-11
Q3 2022 $2.76M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $3.03M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.99M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.25M Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.